Considerable evidence suggests that the development of systemic lupus
erythematosus (SLE) has a strong genetic basis. Recent studies have em
phasized that this disease, like other autoimmune diseases, is a compl
ex genetic trait with contributions from major histocompatibility comp
lex (MHC) genes and multiple non-MHC genes. Etiologic genes in these d
isorders determine susceptibility, and no particular gene is necessary
or sufficient for disease expression. Studies of murine models of lup
us have provided important insight into the immunopathogenesis of IgG
autoantibody production and lupus nephritis, and genetic analyses of t
hese mice overcome certain obstacles encountered when studying patient
s. Genome-wide linkage studies of different crosses have mapped the po
sition of at least 12 non-MHC disease-susceptibility loci in the New Z
ealand hybrid model of lupus. Although the identity of the actual gene
s is currently unknown, recent studies have begun to characterize how
these genetic contributions may function in the autoimmune process, es
pecially in terms of their role in autoantibody production. Studies of
MHC gene contributions in New Zealand mice have shown that heterozygo
sity for particular haplotypes greatly increases pathogenic autoantibo
dy production and the incidence of severe nephritis. The mechanism for
this effect appears to be genetically complex. Studies in human SLE h
ave mostly focused on the association of disease with alleles of immun
ologically relevant genes, especially in the MHC. Associations with va
rious complement component deficiencies and an allele of a particular
Fc gamma receptor gene (FCGR2A) also have been described. In a diversi
on from previous association studies, a recent directed linkage analys
is of sibpairs with SLE was based on mapping studies in murine lupus a
nd may be an important step toward identifying a new disease-susceptib
ility gene in patients. Since the genes that predispose to autoimmunit
y are probably related to key events in pathogenesis, their identifica
tion in patients and murine models will almost certainly provide impor
tant insight into the breakdown of immunological self-tolerance and th
e cause of autoimmune disease.